FNCH logo

Finch Therapeutics (FNCH) Company Overview

Profile

Full Name:

Finch Therapeutics Group, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 19, 2021

Indexes:

Not included

Description:

Finch Therapeutics is a biotechnology company focused on developing microbiome-based therapies. They aim to treat various diseases by restoring the balance of bacteria in the gut. Their innovative approach uses natural microorganisms to improve health and support the body's immune system.

Key Details

Price

$15.00

Annual Revenue

$107.00 K(-87.57% YoY)

Annual EPS

-$46.59(+35.40% YoY)

Annual ROE

-126.06%

Beta

-0.03

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 4, 2025

Recent annual earnings:

Mar 23, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 12, 2023

Analyst ratings

Recent major analysts updates

May 12, 23 HC Wainwright & Co.
Buy
Apr 4, 23 HC Wainwright & Co.
Buy
Aug 9, 22 HC Wainwright & Co.
Buy
Apr 4, 22 Jefferies
Buy
Apr 13, 21 Jefferies
Buy
Apr 13, 21 Evercore ISI Group
Outperform
Apr 13, 21 B of A Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Finch Therapeutics?
  • Does Finch Therapeutics pay dividends?
  • What sector is Finch Therapeutics in?
  • What industry is Finch Therapeutics in?
  • What country is Finch Therapeutics based in?
  • When did Finch Therapeutics go public?
  • Is Finch Therapeutics in the S&P 500?
  • Is Finch Therapeutics in the NASDAQ 100?
  • Is Finch Therapeutics in the Dow Jones?
  • When was Finch Therapeutics's last earnings report?
  • When does Finch Therapeutics report earnings?
  • Should I buy Finch Therapeutics stock now?

What is the ticker symbol for Finch Therapeutics?

The ticker symbol for Finch Therapeutics is NASDAQ:FNCH

Does Finch Therapeutics pay dividends?

No, Finch Therapeutics does not pay dividends

What sector is Finch Therapeutics in?

Finch Therapeutics is in the Healthcare sector

What industry is Finch Therapeutics in?

Finch Therapeutics is in the Biotechnology industry

What country is Finch Therapeutics based in?

Finch Therapeutics is headquartered in United States

When did Finch Therapeutics go public?

Finch Therapeutics's initial public offering (IPO) was on March 19, 2021

Is Finch Therapeutics in the S&P 500?

No, Finch Therapeutics is not included in the S&P 500 index

Is Finch Therapeutics in the NASDAQ 100?

No, Finch Therapeutics is not included in the NASDAQ 100 index

Is Finch Therapeutics in the Dow Jones?

No, Finch Therapeutics is not included in the Dow Jones index

When was Finch Therapeutics's last earnings report?

Finch Therapeutics's most recent earnings report was on Mar 4, 2025

When does Finch Therapeutics report earnings?

The date for Finch Therapeutics's next earnings report has not been announced yet

Should I buy Finch Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions